Cargando…
Classic Prescription, Kai-Xin-San, Ameliorates Alzheimer's Disease as an Effective Multitarget Treatment: From Neurotransmitter to Protein Signaling Pathway
Alzheimer's disease (AD) is a widespread neurodegenerative disease caused by complicated disease-causing factors. Unsatisfactorily, curative effects of approved anti-AD drugs were not good enough due to their actions on single-target, which led to desperate requirements for more effective drug...
Autores principales: | Guo, Sirui, Wang, Jiahong, Xu, Huarong, Rong, Weiwei, Gao, Cheng, Yuan, Ziyue, Xie, Fucheng, Bi, Kaishun, Zhang, Zhou, Li, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636599/ https://www.ncbi.nlm.nih.gov/pubmed/31354916 http://dx.doi.org/10.1155/2019/9096409 |
Ejemplares similares
-
Study on the Multitarget Synergistic Effects of Kai-Xin-San against Alzheimer's Disease Based on Systems Biology
por: Guo, Sirui, et al.
Publicado: (2019) -
Kai Xin San ameliorates scopolamine-induced cognitive dysfunction
por: Xu, Yu-Min, et al.
Publicado: (2019) -
Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease
por: Luo, Yunxia, et al.
Publicado: (2020) -
Antidepressant effects of Kai-Xin-San in fluoxetine-resistant depression rats
por: Dong, X.Z., et al.
Publicado: (2017) -
Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer’s disease
por: Luo, Yunxia, et al.
Publicado: (2023)